Literature DB >> 9180645

Assessing the responsiveness of a functional status measure: the Sickness Impact Profile versus the SIP68.

A F de Bruin1, J P Diederiks, L P de Witte, F C Stevens, H Philipsen.   

Abstract

In this study, the Sickness Impact Profile (SIP) and the SIP68 are studied for their ability to detect changes in health-related behavioral status. Methodological approaches toward responsiveness are invented and discussed. Next, literature findings on the responsiveness of the SIP are presented and judged for their validity. The SIP appeared to be able to demonstrate changes in the expected direction and in accordance with changes detected by other instruments. Using data from seven different longitudinal projects in populations with different diagnoses, the responsiveness of both the SIP136 and the SIP68 are subsequently studied and compared. In all populations, changes in functional status were indicated by both instruments. In terms of effect sizes, the SIP136 and the SIP68 do not differ significantly in their responsiveness. Moreover, changes detected by both SIPs appear to be valid representations of changes in health-related functional status.

Mesh:

Year:  1997        PMID: 9180645     DOI: 10.1016/s0895-4356(97)00047-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  17 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

2.  The SIP68: an abbreviated sickness impact profile for disability outcomes research.

Authors:  Upasana Nanda; Patricia M McLendon; Elena M Andresen; Eric Armbrecht
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

3.  Responsiveness of the QuickDASH and SF-12 in workers with neck or upper extremity musculoskeletal disorders: one-year follow-up.

Authors:  Z Joyce Fan; Caroline K Smith; Barbara A Silverstein
Journal:  J Occup Rehabil       Date:  2011-06

4.  Beyond return to work: testing a measure of at-work disability in workers with musculoskeletal pain.

Authors:  Dorcas E Beaton; Carol A Kennedy
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

5.  Responsiveness to change [corrected] due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer.

Authors:  Julie Lemieux; Dorcas E Beaton; Sheilah Hogg-Johnson; Louise J Bordeleau; Jon Hunter; Pamela J Goodwin
Journal:  Qual Life Res       Date:  2007-05-15       Impact factor: 4.147

Review 6.  Evaluation of instruments for measuring the burden of sport and active recreation injury.

Authors:  Nadine E Andrew; Belinda J Gabbe; Rory Wolfe; Peter A Cameron
Journal:  Sports Med       Date:  2010-02-01       Impact factor: 11.136

7.  Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimum clinically important differences.

Authors:  D Oeffinger; A Bagley; S Rogers; G Gorton; R Kryscio; M Abel; D Damiano; D Barnes; C Tylkowski
Journal:  Dev Med Child Neurol       Date:  2008-12       Impact factor: 5.449

8.  The relationship between pain and functional disability in Black and White older adults.

Authors:  Ann L Horgas; Saunjoo L Yoon; Austin Lee Nichols; Michael Marsiske
Journal:  Res Nurs Health       Date:  2008-08       Impact factor: 2.228

Review 9.  Clinimetric evaluation of shoulder disability questionnaires: a systematic review of the literature.

Authors:  S D M Bot; C B Terwee; D A W M van der Windt; L M Bouter; J Dekker; H C W de Vet
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

10.  Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect.

Authors:  Fausto Salaffi; Piercarlo Sarzi-Puttini; Rita Girolimetti; Stefania Gasparini; Fabiola Atzeni; Walter Grassi
Journal:  Arthritis Res Ther       Date:  2009-08-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.